期刊文献+

埃博拉病毒抗体间接ELISA检测方法的建立及应用 被引量:3

Development of an Indirect ELISA for Detecting Ebola Virus Antibody and Its Application
下载PDF
导出
摘要 为建立EBOV抗体间接ELISA检测方法,以纯化后的EBOV糖蛋白作为包被抗原,HRP标记山羊抗马IgG为二抗,EBOV阳性马血清和阴性马血清分别为阳、阴性对照,优化反应条件,以EBOV病毒样颗粒免疫获得的高免马血清评价其特异性和敏感性,并将检测结果与基于假病毒的中和抗体检测结果相比较,进一步评价EBOV抗体ELISA检测方法在EBOV免疫血清抗体水平检测中的应用。优化后的间接ELISA方法可特异性检测EBOV抗体,与西尼罗病毒等的阳性血清均不发生反应,检测结果与基于假病毒的中和抗体检测结果相平行。批内、批间试验变异系数均小于8%。本研究成功建立了EBOV抗体间接ELISA检测方法,为EBOV免疫血清抗体水平检测提供了一种简便、快速的检测方法。 An indirect ELISA which can detect EBOV antibody was established using the purified the envelope glycoprotein as coating antigen.We use the HRP labeled antibody as the secondary antibody,the positive and negative horse sera as controls.After the reaction conditions were optimized,we analyzed the specificity,sensitivity of the indirect ELISA using serum of horse which immunized with EBOV virus like particles.For further evaluation of application of the ELISA,the results were compared to the neutralization assay based on pseudo-type EBOV.The indirect ELISA could detect the antibody against EBOV specifically and showed no cross-reaction with thepositive sera of West Nile Fever et al.The indirect ELISA also showed high coincidence with the neutralization assay based on pseudo-type EBOV in evaluation of the immune response after immunization.The coefficient of variation of inter-batch and intra-batch duplicative tests was less than 8%.The indirect ELISA was successfully developed.It provides an effective and convenient method to kinetic detection of antibody against EBOV after immunization.
出处 《畜牧兽医学报》 CAS CSCD 北大核心 2016年第3期615-619,共5页 ACTA VETERINARIA ET ZOOTECHNICA SINICA
基金 国家新药创制重大专项(2015ZX09102025)
关键词 埃博拉病毒 糖蛋白(GP) 间接ELISA 抗体检测 Ebola virus(EBOV) envelope glycoprotein(GP) indirect ELISA antibody detection
  • 相关文献

参考文献12

二级参考文献189

  • 1Towner JS, Sealy TK, Khristova ML, et al, Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda [J]. PLoS Pathog , 200S, 4(11): e1000212.
  • 2Kiley MP, Wilusz J, Mccormick JB, et al, Conservation of the 3' terminal nucleotide sequences of Ebola and Marburg virus[J]. Virology, 19S6, 149(2): 251-4.
  • 3Peterson AT. Lash RR. Carroll DS. et al. Geographic potential for outbreaks of Marburg hemorrhagic fever[J]. Am J Trop Med Hyg, 2006. 75(1): 9-15.
  • 4Leroy EM. Kumulungui B, Pourrut X, et al. Fruit bats as reset? voirs of Ebola virus[J]. Nature, 2005. 43S(706S): 575-6.
  • 5Sanchez A, Kiley MP. Identification and analysis of Ebola virus messenger RNA[J]. Virology. 19S7. 157(2): 414-20.
  • 6Manicassamy B. Wang J, Jiang H. et al. Comprehensive analysis of ebola virus GP1 in viral entry [J]. J Virol. 2005. 79(S): 4793 -S05.
  • 7Geisbert TW, Hensley LE. Jahrling PE, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys [J]. Lancet. 2003, 362 (9400): 1953-8.
  • 8Geisbert TW. Hensley LE, Larsen T, et al. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection [J]. Am J Pathol , 2003, 163(6): 2347-70.
  • 9Mehedi M, Groseth A, Feldmann H, et al, Clinical aspects of Marburg hemorrhagic fever [J]. Future Virol. 2011. 6(9): 1091 -106.
  • 10Sullivan NJ, Martin JE, Graham BS, et al. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule [J]. Nat Rev Microbiol, 2009, 7 (5) : 393-400.

共引文献53

同被引文献16

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部